The challenge of viral snRNPs

Cold Spring Harbor Symposia on Quantitative Biology

Volumn 71, Issue , 2006, Pages 377-384

  Conrad, N K ^a   Fok, V ^a   Cazalla, D ^a   Borah, S ^a   Steitz, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ENCODED RNA 1; EPSTEIN BARR VIRUS ENCODED RNA 2; EPSTEIN-BARR VIRUS ENCODED RNA 1; EPSTEIN-BARR VIRUS ENCODED RNA 2; SMALL NUCLEAR RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG; VIRUS RNA; DNA DIRECTED RNA POLYMERASE III; POLYADENYLATED RNA; RIBOSOMAL PROTEIN L22; RIBOSOME PROTEIN; VIRAL PROTEIN;

ANIMAL; B LYMPHOCYTE; CHEMISTRY; CONFORMATION; EPSTEIN BARR VIRUS; GENETICS; HERPES VIRUS SAIMIRI; HUMAN; HUMAN HERPESVIRUS 8; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVIEW; VIROLOGY; ARTICLE; CELL NUCLEUS; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION; HAPLORHINI; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; RNA DEGRADATION; SAIMIRIINE HERPESVIRUS 2; T CELL LEUKEMIA; T CELL LYMPHOMA; T LYMPHOCYTE; VIRUS GENE; WILD TYPE;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; HERPESVIRUS 2, SAIMIRIINE; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; RIBONUCLEOPROTEINS, SMALL NUCLEAR; RNA, VIRAL;

EID: 34250681447     PISSN: 00917451     EISSN: None     Source Type: Book Series    
DOI: 10.1101/sqb.2006.71.057     Document Type: Conference Paper

References (79)

1. Albrecht J.C. 2000. Primary structure of the Herpesvirus ateles genome. J. Virol. 74: 1033.
2. Albrecht J.C. and Fleckenstein B. 1992. Nucleotide sequence of HSUR 6 and HSUR 7, two small RNAs of herpesvirus saimiri. Nucleic Acids Res. 20: 1810.
3. Barletta J.M., Kingma D.W., Ling Y., Charache P., Mann R.B., and Ambinder R.F. 1993. Rapid in situ hybridization for the diagnosis of latent Epstein-Barr virus infection. Mol. Cell. Probes 7: 105.
4. Bhat R.A. and Thimmappaya B. 1983. Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl. Acad. Sci. 80: 4789.
5. Bousquet-Antonelli C., Presutti C., and Tollervey D. 2000. Identification of a regulated pathway for nuclear pre-mRNA turnover. Cell 102: 765.
6. Chang P.J., Shedd D., Gradoville L., Cho M.S., Chen L.W., Chang J., and Miller G. 2002. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J. Virol. 76: 3168.1
7. Cho M.S., Yee H., and Chan S. 2002. Establishment of a human somatic hybrid cell line for recombinant protein production. J. Biomed. Sci. 9: 631.
8. Collis P., Antoniou M., and Grosveld F. 1990. Definition of the minimal requirements within the human beta-globin gene and the dominant control region for high level expression. EMBO J. 9: 233.
9. Conrad N.K. and Steitz J.A. 2005. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J. 24: 1831.
10. Conrad N.K., Mili S., Shu M.-D., Marshall E.L., and Steitz J.A. 2006. Identification of a rapid mammalian deadenylation-dependent decay pathway and its inhibition by a viral RNA element. Mol. Cell (in press).
11. Cook H.L., Mischo H.E., and Steitz J.A. 2004. The Herpesvirus saimiri small nuclear RNAs recruit AU-rich element-binding proteins but do not alter host AU-rich element-containing mRNA levels in virally transformed T cells. Mol. Cell. Biol. 24: 4522.
12. Cook H.L., Lytle J.R., Mischo H.E., Li M.J., Rossi J.J., Silva D.P., Desrosiers R.C., and Steitz J.A. 2005. Small nuclear RNAs encoded by Herpesvirus saimiri upregulate the expression of genes linked to T cell activation in virally transformed T cells. Curr. Biol. 15: 974.
13. Cullen B.R. 2006. Viruses and microRNAs. Nat. Genet. (suppl.) 38: S25.
14. Das B., Butler J.S., and Sherman F. 2003. Degradation of normal mRNA in the nucleus of Saccharomyces cerevisiae. Mol. Cell. Biol. 23: 5502.
15. Dobbelstein M. and Shenk T. 1995. In vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by using randomized and cDNA-derived RNA libraries. J. Virol. 69: 8027.
16. Fan X.C. and Steitz J.A. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17: 3448.
17. Faria P.A., Chakraborty P., Levay A., Barber G.N., Ezelle H.J., Enninga J., Arana C., van Deursen J., and Fontoura B.M. 2005. VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway. Mol. Cell 17: 93.
18. Fasken M.B. and Corbett A.H. 2005. Process or perish: Quality control in mRNA biogenesis. Nat. Struct. Mol. Biol. 12: 482.
19. Fok V., Friend K., and Steitz J.A. 2006a. Epstein-Barr virus non-coding RNAs are confined to the nucleus, whereas their partner, the human La protein, undergoes nucleocytoplasmic shuttling. J. Cell Biol. 173: 319.
20. Fok V., Mitton-Fry R., Grech A., and Steitz J.A. 2006b. Multiple domains of EBER 1, an Epstein-Barr virus non-coding RNA, recruit human ribosomal protein L22. RNA 12: 872.
21. Ford L.P., Watson J., Keene J.D., and Wilusz J. 1999. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev. 13: 188.
22. Golembe T.J., Yong J., Battle D.J., Feng W., Wan L., and Dreyfuss G. 2005. Lymphotropic Herpesvirus saimiri uses the SMN complex to assemble Sm cores on its small RNAs. Mol. Cell. Biol. 25: 602.
23. Goodrich J.A. and Kugel J.F. 2006. Non-coding-RNA regulators of RNA polymerase II transcription. Nat. Rev. Mol. Cell Biol. 7: 12.
24. Han Z. and Swaminathan S. 2006. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol. 80: 5251.
25. He B., Gross M., and Roizman B. 1997. The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shut-off of protein synthesis by double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. 94: 843.
26. Hilleren P., McCarthy T., Rosbash M., Parker R., and Jensen T.H. 2001. Quality control of mRNA 3′-end processing is linked to the nuclear exosome. Nature 413: 538.
27. Howe J.G. and Steitz J.A. 1986. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. Proc. Natl. Acad. Sci. 83: 9006.
28. Huang Y. and Carmichael G.G. 1997. The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1-related mRNAs. Proc. Natl. Acad. Sci. 94: 10104.
29. Huang Y., Wimler K.M., and Carmichael G.G. 1999. Intronless mRNA transport elements may affect multiple steps of prem-RNA processing. EMBO J. 18: 1642.
30. Iwakiri D., Eizuru Y., Tokunaga M., and Takada K. 2003. Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 63: 7062.
31. Jensen T.H., Boulay J., Olesen J.R., Colin J., Weyler M., and Libri D. 2004. Modulation of transcription affects mRNP quality. Mol. Cell 16: 235.
32. Kadaba S., Krueger A., Trice T., Krecic A.M., Hinnebusch A.G., and Anderson J. 2004. Nuclear surveillance and degradation of hypomodified initiator tRNAMet in S. cerevisiae. Genes Dev. 18: 1227.
33. Kieff E. and Liebowitz D. 1990. Epstein-Barr virus and its replication. In Fields virology, 2nd edition (ed. D.M. Knipe et al.), p. 1889. Raven Press, New York.
34. Kiss T. 2002. Small nucleolar RNAs: An abundant group of non-coding RNAs with diverse cellular functions. Cell 109: 145.
35. - RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J. 19: 6742.
36. Komano J., Maruo S., Kurozumi K., Oda T., and Takada K. 1999. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata. J. Virol. 73: 9827.
37. Kuai L., Das B., and Sherman F. 2005. A nuclear degradation pathway controls the abundance of normal mRNAs in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. 102: 13962.
38. LaCava J., Houseley J., Saveanu C., Petfalski E., Thompson E., Jacquier A., and Tollervey D. 2005. RNA degradation by the exosome is promoted by a nuclear polyadenylation complex. Cell 121: 713.
39. Lee S.I., Murthy S.C., Trimble J.J., Desrosiers R.C., and Steitz J.A. 1988. Four novel U RNAs are encoded by a herpesvirus. Cell 54: 599.
40. Lerner M.R., Andrews N.C., Miller G., and Steitz J.A. 1981. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. 78: 805.
41. Li M.J., Bauer G., Michienzi A., Yee J.K., Lee N.S., Kim J., Li S., Castanotto D., Zaia J., and Rossi J.J. 2003. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 8: 196.
42. Libri D., Dower K., Boulay J., Thomsen R., Rosbash M., and Jensen T.H. 2002. Interactions between mRNA export commitment, 3′-end quality control, and nuclear degradation. Mol. Cell. Biol. 22: 8254.
43. Loflin P., Chen C.Y., and Shyu A.B. 1999a. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13: 1884.
44. Loflin P.T., Chen C.Y., Xu N., and Shyu A.B. 1999b. Transcriptional pulsing approaches for analysis of mRNA turnover in mammalian cells. Methods 17: 11.
45. Luna R.E., Zhou F., Baghian A., Chouljenko V., Forghani B., Gao S.J., and Kousoulas K.G. 2004. Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J. Virol. 78: 6389.
46. Mathews M.B. and Shenk T. 1991. Adenovirus virus-associated RNA and translation control. J. Virol. 65: 5657.
47. McKenna S.A., Kim I., Liu C.W., and Puglisi J.D. 2006. Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs. J. Mol. Biol. 358: 1270.
48. Milligan L., Torchet C., Allmang C., Shipman T., and Tollervey D. 2005. A nuclear surveillance pathway for mRNAs with defective polyadenylation. Mol. Cell. Biol. 25: 9996.
49. Mohr I. and Gluzman Y. 1996. A herpesvirus genetic element which affects translation in the absence of the viral GADD34 function. EMBO J. 15: 4759.
50. Moore M.J. 2002. Nuclear RNA turnover. Cell 108: 431.
51. Muhlrad D. and Parker R. 2005. The yeast EDC1 mRNA undergoes deadenylation-independent decapping stimulated by Not2p, Not4p, and Not5p. EMBO J. 24: 1033.
52. Murthy S.C., Trimble J.J., and Desrosiers R.C. 1989. Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J. Virol. 63: 3307.
53. Myer V.E., Lee S.I., and Steitz J.A. 1992. Viral small nuclear ribonucleoproteins bind a protein implicated in messenger RNA destabilization. Proc. Natl. Acad. Sci. 89: 1296.
54. Nair V. and Zavolan M. 2006. Virus-encoded microRNAs: Novel regulators of gene expression. Trends Microbiol. 14: 169.
55. Nissen P., Ippolito J.A., Ban N., Moore P.B., and Steitz T.A. 2001. RNA tertiary interactions in the large ribosomal sub-unit: The A-minor motif. Proc. Natl. Acad. Sci. 98: 4899.
56. Ruf I.K., Lackey K.A., Warudkar S., and Sample J.T. 2005. Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. J. Virol. 79: 14562.
57. Ruf I.K., Rhyne P.W., Yang C., Cleveland J.L., and Sample J.T. 2000. Epstein-Barr virus small RNAs potentiate tumorigenicity of Burkitt lymphoma cells independently of an effect on apoptosis. J. Virol. 74: 10223.
58. Sharp T.V., Schwemmle M., Jeffrey I., Laing K., Mellor H., Proud C.G., Hilse K., and Clemens M.J. 1993. Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus RNAs EBER-1 and EBER-2 and adenovirus VAI RNA. Nucleic Acids Res. 21: 4483.
59. Shaw G. and Kamen R. 1986. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659.
60. Song M.J., Brown H.J., Wu T.T., and Sun R. 2001. Transcription activation of polyadenylated nuclear RNA by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus. J. Virol. 75: 3129.
61. Sun R., Lin S.F., Gradoville L., and Miller G. 1996. Polyadenylylated nuclear RNA encoded by Kaposi sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. 93: 11883.
62. Swaminathan S., Tomkinson B., and Kieff E. 1991. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. 88: 1546.
63. Takizawa T., Tatematsu C., Watanabe M., Yoshida M., and Nakajima K. 2000. Three leucine-rich sequences and the N-terminal region of double-stranded RNA-activated protein kinase (PKR) are responsible for its cytoplasmic localization. J. Biochem. 128: 471.
64. Taylor J.L., Bennett H.N., Snyder B.A., Moore P.S., and Chang Y. 2005. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J. Virol. 79: 15099.
65. Toczyski D.P. and Steitz J.A. 1993. The cellular RNA-binding protein EAP recognizes a conserved stem-loop in the Epstein-Barr virus small RNA EBER 1. Mol. Cell. Biol. 13: 703.
66. Toczyski D.P., Matera A.G., Ward D.C., and Steitz J.A. 1994. The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc. Natl. Acad. Sci. 91: 3463.
67. Tycowski K.T., Kolev N.G., Conrad N.K., Fok V., and Steitz J.A. 2006. The ever-growing world of small nuclear ribonu-cleoproteins. In The RNA world, 3rd edition (ed. R.F. Gesteland et al.), p. 327. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
68. Vanacova S., Wolf J., Martin G., Blank D., Dettwiler S., Friedlein A., Langen H., Keith G., and Keller W. 2005. A new yeast poly(A) polymerase complex involved in RNA quality control. PLoS Biol. 3: e189.
69. Viejo-Borbolla A., Ottinger M., and Schulz T.F. 2004. Human herpesvirus 8: Biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies. Curr. HIV/AIDS Rep. 1: 5.
70. Vuyisich M., Spanggord R.J., and Beal P.A. 2002. The binding site of the RNA-dependent protein kinase (PKR) on EBER1 RNA from Epstein-Barr virus. EMBO Rep. 3: 622.
71. Wang H.W., Sharp T.V., Koumi A., Koentges G., and Boshoff C. 2002. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J. 21: 2602.
72. Wang Y., Xue S.A., Hallden G., Francis J., Yuan M., Griffin B.E., and Lemoine N.R. 2005. Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors. Cancer Res. 65: 1523.
73. Wyers F., Rougemaille M., Badis G., Rousselle J.C., Dufour M.E., Boulay J., Regnault B., Devaux F., Namane A., Seraphin B., et al. 2005. Cryptic pol II transcripts are degraded by a nuclear quality control pathway involving a new poly(A) polymerase. Cell 121: 725.
74. Xu Y., AuCoin D.P., Huete A.R., Cei S.A., Hanson L.J., and Pari G.S. 2005. A Kaposi's sarcoma-associated herpesvirus/ human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 79: 3479.
75. Yamamoto N., Takizawa T., Iwanaga Y., Shimizu N., and Yamamoto N. 2000. Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett. 484: 153.
76. Yang L., Aozasa K., Oshimi K., and Takada K. 2004. Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 64: 5332.
77. Ye F.C., Zhou F.C., Yoo S.M., Xie J.P., Browning P.J., and Gao S.J. 2004. Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J. Virol. 78: 11121.
78. Zhong W., Wang H., Herndier B., and Ganem D. 1996. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. 93: 6641.
79. Zhou F.C., Zhang Y.J., Deng J.H., Wang X.P., Pan H.Y., Hettler E., and Gao S.J. 2002. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: Application for genetic analysis. J. Virol. 76: 6185